Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-08-13
DOI
10.1002/med.21528
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- What if you knew the prognosis of your patients with ALS?
- (2018) Hiroshi Mitsumoto LANCET NEUROLOGY
- Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study
- (2018) Ton Fang et al. LANCET NEUROLOGY
- Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model
- (2018) Henk-Jan Westeneng et al. LANCET NEUROLOGY
- Stephen Hawking (1942–2018)
- (2018) John Preskill SCIENCE
- Clinical efficacy of edaravone for the treatment of amyotrophic lateral sclerosis
- (2017) Hideyuki Sawada EXPERT OPINION ON PHARMACOTHERAPY
- Edaravone for treatment of early-stage ALS
- (2017) Jesús S Mora LANCET NEUROLOGY
- Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
- (2017) Koji Abe et al. LANCET NEUROLOGY
- Therapeutic opportunities and challenges of induced pluripotent stem cells-derived motor neurons for treatment of amyotrophic lateral sclerosis and motor neuron disease
- (2017) ManojKumar Jaiswal Neural Regeneration Research
- Post-hoc analysis of MCI186-17, the extension study to MCI186-16, the confirmatory double-blind, parallel-group, placebo-controlled study of edaravone in amyotrophic lateral sclerosis
- (2017) Fumihiro Takahashi et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Exploratory double-blind, parallel-group, placebo-controlled extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis
- (2017) Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Generation of a Motor Nerve Organoid with Human Stem Cell-Derived Neurons
- (2017) Jiro Kawada et al. Stem Cell Reports
- Endothelial and Astrocytic Support by Human Bone Marrow Stem Cell Grafts into Symptomatic ALS Mice towards Blood-Spinal Cord Barrier Repair
- (2017) Svitlana Garbuzova-Davis et al. Scientific Reports
- Selective Motor Neuron Resistance and Recovery in a New Inducible Mouse Model of TDP-43 Proteinopathy
- (2016) K. J. Spiller et al. JOURNAL OF NEUROSCIENCE
- Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs
- (2016) Jie Jiang et al. NEURON
- Promise and Pitfalls of Mitochondrial Replacement for Prevention and Cure of Heritable Neurodegenerative Diseases Caused by Deleterious Mutations in Mitochondrial DNA
- (2016) Ananta Paine et al. Frontiers in Cellular Neuroscience
- Edaravone leads to proteome changes indicative of neuronal cell protection in response to oxidative stress
- (2015) Mohammad-Saeid Jami et al. NEUROCHEMISTRY INTERNATIONAL
- Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
- (2014) Hiroshi Mitsumoto et al. LANCET NEUROLOGY
- Preclinical research: Make mouse studies work
- (2014) Steve Perrin NATURE
- Neuronal Matrix Metalloproteinase-9 Is a Determinant of Selective Neurodegeneration
- (2014) Artem Kaplan et al. NEURON
- Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients
- (2014) Koji Abe et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Improving basic and translational science by accounting for litter-to-litter variation in animal models
- (2013) Stanley E Lazic et al. BMC NEUROSCIENCE
- C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS
- (2013) Theo Hatzipetros et al. BRAIN RESEARCH
- PGC-1 is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis
- (2013) J. Eschbach et al. HUMAN MOLECULAR GENETICS
- Calcium, mitochondria, and the pathogenesis of ALS: the good, the bad, and the ugly
- (2013) Manoj Kumar Jaiswal Frontiers in Cellular Neuroscience
- The need for littermate controls
- (2011) Rikard Holmdahl et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- How can we improve clinical trials in amyotrophic lateral sclerosis?
- (2011) Paul H. Gordon et al. Nature Reviews Neurology
- ALS clinical trials: Do enrolled patients accurately represent the ALS population?
- (2011) A. Chio et al. NEUROLOGY
- Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: Examining a more efficient trial design
- (2011) R. G. Miller et al. NEUROLOGY
- OH Radical Scavenging Activity of Edaravone: Mechanism and Kinetics
- (2010) Adriana Pérez-González et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Gender-based effect of statins on functional decline in amyotrophic lateral sclerosis
- (2010) Beatrice Nefussy et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
- (2010) Carol Kilkenny et al. PLOS BIOLOGY
- Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease
- (2009) Manoj Jaiswal et al. BMC NEUROSCIENCE
- Legumes, lemons and streptomycin: A short history of the clinical trial
- (2009) R. Collier CANADIAN MEDICAL ASSOCIATION JOURNAL
- Scrutinizing enrollment in ALS clinical trials: Room for improvement?
- (2008) Richard S. Bedlack et al. Amyotrophic Lateral Sclerosis
- Cu/Zn Superoxide Dismutase Typical for Familial Amyotrophic Lateral Sclerosis Increases the Vulnerability of Mitochondria and Perturbs Ca2+ Homeostasis in SOD1G93A Mice
- (2008) M. K. Jaiswal et al. MOLECULAR PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started